1. Home
  2. RDW vs BLTE Comparison

RDW vs BLTE Comparison

Compare RDW & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDW
  • BLTE
  • Stock Information
  • Founded
  • RDW 2020
  • BLTE 2018
  • Country
  • RDW United States
  • BLTE United States
  • Employees
  • RDW N/A
  • BLTE N/A
  • Industry
  • RDW Military/Government/Technical
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDW Industrials
  • BLTE Health Care
  • Exchange
  • RDW Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • RDW 2.2B
  • BLTE 2.1B
  • IPO Year
  • RDW N/A
  • BLTE 2022
  • Fundamental
  • Price
  • RDW $16.09
  • BLTE $62.24
  • Analyst Decision
  • RDW Strong Buy
  • BLTE Strong Buy
  • Analyst Count
  • RDW 8
  • BLTE 4
  • Target Price
  • RDW $17.91
  • BLTE $96.67
  • AVG Volume (30 Days)
  • RDW 4.0M
  • BLTE 71.7K
  • Earning Date
  • RDW 08-06-2025
  • BLTE 08-08-2025
  • Dividend Yield
  • RDW N/A
  • BLTE N/A
  • EPS Growth
  • RDW N/A
  • BLTE N/A
  • EPS
  • RDW N/A
  • BLTE N/A
  • Revenue
  • RDW $277,704,000.00
  • BLTE N/A
  • Revenue This Year
  • RDW $46.40
  • BLTE N/A
  • Revenue Next Year
  • RDW $44.30
  • BLTE N/A
  • P/E Ratio
  • RDW N/A
  • BLTE N/A
  • Revenue Growth
  • RDW 1.36
  • BLTE N/A
  • 52 Week Low
  • RDW $4.87
  • BLTE $43.70
  • 52 Week High
  • RDW $26.66
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • RDW 47.61
  • BLTE 53.07
  • Support Level
  • RDW $15.88
  • BLTE $59.12
  • Resistance Level
  • RDW $20.33
  • BLTE $62.64
  • Average True Range (ATR)
  • RDW 1.33
  • BLTE 2.29
  • MACD
  • RDW -0.16
  • BLTE 0.11
  • Stochastic Oscillator
  • RDW 24.56
  • BLTE 53.14

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: